Showing results 1 to 20 of 98
next >
| Issue Date | Title | Author(s) |
| 10-Aug-2022 | ACBD3 bioinformatic analysis and protein expression in breast cancer cells | Houghton-Gisby, J; Kerslake, R; Karteris, E; Mokbel, K; Harvey, AJ |
| 2025 | Alterations in Interphase Chromosome Positioning and Nuclear Myosin Iβ and VI in Ovarian Cancer Cells, and the Reversal of Cisplatin Chemo resistance upon knock-down of Nuclear Myosin Iβ | Sammy, A; Karteris, E; Riyahi, K; Bridger, J |
| 2015 | Amplification efficiency and thermal stability of qPCR instrumentation: Current landscape and future perspectives | Rogers-Broadway, KR; Karteris, E |
| 23-Dec-2022 | Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway | Shabir, K; Gharanei, S; Orton, S; Patel, V; Chauhan, P; Karteris, E; Randeva, HS; Brown, JE; Kyrou, I |
| 24-Jan-2025 | The Association Between Metabolic Syndrome and the Risk of Endometrial Cancer in Pre- and Post-Menopausal Women: A UK Biobank Study | Karkia, R; Maccarthy, G; Payne, A; Karteris, E; Pazoki, R; Chatterjee, J |
| 26-Aug-2021 | Canonical NF-κB promotes lung epithelial cell tumour growth by downregulating the metastasis suppressor CD82 and enhancing epithelial-to-mesenchymal cell transition | Roupakia, E; Chavdoula, E; Karpathiou, G; Vatsellas, G; Chatzopoulos, D; Mela, A; Gillette, JM; Kriegsmann, K; Kriegsmann, M; Batistatou, A; Goussia, A; Marcu, KB; Karteris, E; Klinakis, A; Kolettas, E |
| 7-Sep-2021 | Circulating tumour cells and circulating cell-free DNA in lung cancer patients: A comparison between Thoracotomy and Video-Assisted Thoracoscopic Surgery | Katopodis, P; Anikin, V; Kishore, U; Carter, T; Hall, M; Asadi, N; Polychronis, A; Karteris, E |
| 2010 | Congenital imperforate hymen with hydrocolpos and hydronephrosis associated with severe hydramnios and increase of maternal ovarian steroidogenic enzymes | Karteris, E; Foster, H; Karamouti, M; Goumenou, A |
| 26-Feb-2021 | COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease | Katopodis, P; Kerslake, R; Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Anikin, V; Polychronis, A; Robertus, JL; Kyrou, I; Karteris, E |
| 2020 | Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom | Kerslake, R; Hall, M; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 2012 | Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma | Zachariades, E; Mparmpakas, D; Thomas, P; Rand-Weaver, M; Karteris, E |
| 4-Jan-2023 | Deciphering the Role of microRNA Mediated Regulation of Coronin 1C in Glioblastoma Development and Metastasis | Mustafov, D; Karteris, E; Braoudaki, M |
| 25-Mar-2023 | Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting | Alizzi, Z; Roxburgh, P; Cartwright, D; McLaren, A; Park, S; Jones, R; Greening, S; Hudson, E; Green, C; Gray, S; Khalique, S; Karteris, E; Hall, M |
| 17-Jul-2019 | Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer | Kumar, J; Chudasama, D; Charlotee, R; Kubista, M; Sjoback, R; Chatterjee, J; Anikin, V; Karteris, E; Hall, M |
| 2018 | The Development and Characterisation of Everolimus Resistant Breast Cancer Cells | Hare, Stephen |
| 15-Jun-2023 | Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study | Alizzi, Z; Gogbashian, A; Karteris, E; Hall, M |
| 25-Sep-2022 | Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis | Karkia, R; Wali, S; Payne, A; Karteris, E; Chatterjee, J |
| 2016 | Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro | Rogers-Broadway, KR; Chudasama, D; Pados, G; Tsolakidis, D; Goumenou, A; Hall, M; Karteris, E |
| 31-Oct-2018 | Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry | Rogers‑Broadway, KR; Kumar, J; Sisu, C; Wander, G; Mazey, E; Jeyaneethi, J; Pados, G; Tsolakidis, D; Klonos, E; Grunt, T; Hall, M; Chatterjee, J; Karteris, E |
| 2010 | Differential expression of mTOR signalling components in drug resistance in ovarian cancer | Foster, H; Coley, HM; Goumenou, A; Pados, G; Harvey, AJ; Karteris, E |
